News | 24 August 2011
The Chairman and Chief Executive Officer of the the company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, Dr. Eric A. Rose commented, "This grant is a continuation of our vibrant, long-term relationship with ...
Click on the link to read the full article at Small Cap Network
(This link will open in a new window)